Jerlyn O'Donnell, founder of Design Lady LLC, standing among tropical foliage in an editorial portrait

FDA Approved Aesthetic Solution · NDA 2026-DL

Breakthrough Treatment for Chronic
Sub-par Interfaces.

Jerlyn O'Donnell™ (designlady) is now indicated for the immediate improvement of User Experience and Brand Aesthetic in digital ecosystems suffering from Chronic Interface Dermatitis (CID).

Schedule a call

All designer images are AI-generated.

Side Effects

Obsessive kerning, extreme satisfaction with line-height, sudden desire for custom illustration, heightened expectations for every subsequent project.

Common Adverse Reactions

Rapid promotion within the organization. Extreme stakeholder satisfaction. Accidental virality on social platforms.

Rare Reactions

Uncontrollable urge to fix every font on the internet. Spontaneous applause during presentations. Development of a "refined palette."

Contraindications & Warnings

Do not use if allergic to high-quality design or prefer Comic Sans. Highly addictive; prolonged exposure may reduce tolerance for non-expert design partners.

$0: New business generated via accessible design proposals
0: Virtual congress visitors in one week, vs. 447 avg in-person
0: AI applications shipped in under 6 months
0: Years in continuous clinical practice across regulated, high-stakes platforms

Drug Facts

Active Ingredients & Mechanism of Action

Active Ingredients

What's Inside Each Dose

100mg Figma Precision
50mg AI Workflow Stability
200mcg Typographic Focus

Dosage & Administration

Recommended Regimen

One design sprint every 2 weeks until symptoms of "Default Bootstrap" fully subside. For acute brand emergencies, a loading dose of one prototype delivered in under 48 hours. Not recommended for projects with zero stakeholder alignment.

Phase III Results 99.8%

Reduction in user friction.
Statistically significant
(P < 0.001) vs. Bootstrap Placebo.

Discovery

Molecular analysis of the brand landscape and DNA.

Ideation

Rapid synthesis of visual concepts, forming multiple pathways.

Execution

Crystallization of the chosen concept into a production-ready design system.

Iteration

Post-launch analysis and AI-assisted refinement.

Study DP-003 · Phase III Clinical Data

Clinical Use Cases

Client-confidential case study thumbnail for Virtual Congress Experience — sign in to view

Client-Confidential
Sign in to view

Regulated Healthcare · 2020

Recognition

Verified & Approved

IAAP Certified CPACC Adobe Community Expert WCAG 2.1 AA: 76% → 94% compliance 98% reduction in CSS bloat

Patient History

Fifteen-plus years administering Experience Design Director-strength treatment to high-stakes, regulated, expert-facing digital platforms — the kind where a bad interface doesn't just annoy someone, it costs a diagnosis, a vaccination, a booth conversation that should've happened in Singapore instead of a parking lot in Secaucus. IAAP CPACC certified (the closest thing this field has to a medical board). Adobe Community Expert. Co-author, The Hybrid Business Engineer in the Age of AI — required reading for anyone who thinks "AI strategy" and "actually shipping something" are the same sentence.

No known contraindications with high standards.